financetom
Business
financetom
/
Business
/
Nippon Paint to repurchase India businesses from Singapore's Wuthelam Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nippon Paint to repurchase India businesses from Singapore's Wuthelam Group
Aug 29, 2023 8:28 AM

Japan's largest coatings maker Nippon Paint Holdings will repurchase Nippon Paint (India) and Berger Nippon Paint Automotive Coatings for 14.5 billion yen from Singaporean paint conglomerate Wuthelam Group, Bloomberg reported. The deal is set to be completed in the first half of 2024.

Share Market Live

NSE

As per the details put out, Berger Paints India will continue to own 49 percent stake in the automotive coatings venture. As of now, the Wuthelam Group owns 58.7 percent stake in Nippon Paint Holdings.

Nippon Paint said the Indian businesses have good prospects for sustained profit growth.

Earlier in 2020, Wuthelam planned to acquire a majority stake in Nippon Paint Holdings in a deal valued at roughly 1.3 trillion yen ($12.3 billion). Nippon had also executed a call option for the businesses, which it sold for combined 10.8 billion yen in 2021.

Also Read:India's largest paint manufacturer is gearing up for a colourful festive season

With inputs from Bloomberg

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition
Longevity Biomedical to Go Public in SPAC deal with FutureTech II Acquisition
Sep 21, 2024
03:56 PM EDT, 09/20/2024 (MT Newswires) -- Blank-check firm FutureTech II Acquisition ( FTII ) agreed to a merger agreement earlier this week and take Longevity Biomedical public, the companies said Friday. The combined company will operate as Longevity Biomedical and is expected to list on Nasdaq under the LBIO ticker, the companies said. The new company will have approximately...
Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing
Rev Group Insider Sold Shares Worth $356,250, According to a Recent SEC Filing
Sep 21, 2024
04:09 PM EDT, 09/20/2024 (MT Newswires) -- Charles Dutil, Director, on September 18, 2024, sold 12,500 shares in Rev Group ( REVG ) for $356,250. Following the Form 4 filing with the SEC, Dutil has control over a total of 41,628 shares of the company, with 41,628 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1687221/000095010324013803/xslF345X05/dp218237_4.xml Price: 27.61, Change: -0.01, Percent Change: -0.04...
Sanofi wins US approval for drug combination to treat multiple myeloma
Sanofi wins US approval for drug combination to treat multiple myeloma
Sep 21, 2024
Sept 20 - Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed multiple myeloma, where it has previously been used only after standard treatments have failed, the U.S. Food and Drug Administration said on Friday. ...
Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing
Rbc Bearings Insider Sold Shares Worth $837,202, According to a Recent SEC Filing
Sep 21, 2024
04:08 PM EDT, 09/20/2024 (MT Newswires) -- Edward Stewart, Director, on September 20, 2024, sold 2,800 shares in Rbc Bearings ( RBC ) for $837,202. Following the Form 4 filing with the SEC, Stewart has control over a total of 20,461 shares of the company, with 20,461 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1324948/000159396824001214/xslF345X05/primary_01.xml Price: 295.45, Change: +0.11, Percent Change: +0.04...
Copyright 2023-2026 - www.financetom.com All Rights Reserved